Posted by Two Blokes
If you wonder whether Abbott Laboratories NYSE: ABT is a good buy in Q2 2025, the answer is yes. The company's
Source: Two Blokes Trading
Posted by Two Blokes
KDP's Q2 results are likely to reflect benefits from strong beverage demand, GHOST acquisition gains and innov
Source: Two Blokes Trading
Posted by Two Blokes
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TV
Source: Two Blokes Trading
Posted by Two Blokes
LTC has finally broken out of weeks of sideways action, closing above a key resistance zone.
Source: Two Blokes Trading
Posted by Two Blokes
As a result of three big crypto bills passing in the US House and a daily spike in Bitcoin, Ether, and XRP, am
Source: Two Blokes Trading
Posted by Two Blokes
It isn't just the U.S. Other countries have also come to expect an independent U.S. central bank.
Source: Two Blokes Trading
Posted by Two Blokes
A WSJ survey shows less pessimism regarding the second quarter. Uncertainty over trade policy and immigration
Source: Two Blokes Trading
Posted by Two Blokes
CNBC's Hugh Son joins 'Money Movers' to discuss takeaways from American Express' earnings call.
Source: Two Blokes Trading
Posted by Two Blokes
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquir
Source: Two Blokes Trading
Posted by Two Blokes
Jason Helfstein, Oppenheimer senior internet analyst, joins 'Money Movers' to discuss his takeaways from Netfl
Source: Two Blokes Trading
Posted by Two Blokes
JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvyk
Source: Two Blokes Trading
Posted by Two Blokes
US mutual funds trace their origin to 1924's Massachusetts Investors Trust, which was the first formalized US
Source: Two Blokes Trading